Orikami develops digital solutions for remote home monitoring according to the highest quality standards of the European Medical Device Regulation (MDR). Earlier this year we started the certification process of our Quality Management System according to…
News
Bert Seegers new CEO Orikami
As of October 1, 2022, Bert Seegers is the new CEO of Orikami. Bert has contributed to the growth of Orikami over the past 5 years as Chief Business Officer. Orikami will be pursuing a…
Measuring participation in MS with the Whereabouts app
Multiple Sclerosis can impact daily life and involvement in societal activities (participation). How do you decide which activities you want to participate in? The MS Center Amsterdam and Orikami have developed the smartphone application ‘Whereabouts’…
Becoming a better data scientist: Lessons from academia and industry
The start, scope and design of your project Any good data science project starts with the end goal in mind. The number of possible analyses for a given data set is potentially limitless, and without…
Innovation Origins: Digital biomarkers let doctor see how patients are really doing
With specially developed digital biomarkers, you can measure a patient’s health more objectively. This allows doctors to get a better picture of a patient. “In the consultation room, a doctor often only gets a limited…
Digital Health companies in the Nijmegen region
Orikami is featured in the Digital Health Brochure Nijmegen region! Health Valley Netherlands has published a Digital Health Guide together with Radboudumc, Novio Tech Campus, Gemeente Nijmegen and Briskr. The aim: to connect Digital Health players in the Nijmegen…
OpenPlanet
The activities listed below are made possible by the European Union. OpenPlanet is a collaboration between OnePlanet Research Center, iMEC, JoinData, Ivido and Stichting SIDN. By combining the strengths of all partners OnePlanet aims to…
Orikami is the Best Digital Biomarker Company 2021
We are excited to announce that Orikami is mentioned on the Global Health & Pharma website. This year Orikami is a winner in the Healthcare and Pharmaceutical Awards 2021. We are honored for being recognized…
Orikami & Radboudumc, Department of Geriatrics
Highlighted by the need for new, large-scale dementia-prevention and treatment trials, clinicians and researchers urgently need improved tools for remote monitoring of cognitive performance. Commonly used tests are not designed for frequent, remote testing in…
PROMPT – Freezing of Gait / Balance Digital Biomarker
The activities listed below are made possible by the European Union. PROMPT (Personalised-care and Research On Motoric-dysfunctioning for Patient-specific Treatments) project receives a subsidy for the following activity(s): Development of an integrated system for the…
- 1
- 2